GlassScriptPhysician profile
Shawn Cassady
NPI 1902912918
$1,938.82
in general payments reported to CMS, 2019-2025
15 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $158 · 2021: $491 · 2022: $244 · 2023: $175 · 2024: $281 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $723.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $533.98 | 2019-2021 | |
| Alkermes, INC. | $214.24 | 2019-2025 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $192.09 | 2019-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Abbvie INC. | $186.65 | 2023-2025 | Vraylar |
| Corium, LLC | $180.69 | 2022-2024 | Azstarys |
| Janssen Pharmaceuticals, INC | $151.81 | 2019-2025 | Spravato, Invega Sustenna |
| Lundbeck LLC | $102.70 | 2021-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $92.17 | 2021-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $65.28 | 2024-2025 | Uzedy, Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $61.15 | 2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $56.70 | 2021-2023 | |
| Supernus Pharmaceuticals, INC. | $37.88 | 2021-2022 | |
| Allergan, INC. | $32.17 | 2019 | |
| Vanda Pharmaceuticals INC. | $21.82 | 2024 | Fanapt, Hetlioz |
| Tms Neurohealth Centers INC. | $9.49 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Cassady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.